Fisher-Price Rock ‘n Play Sleeper Recall Reannounced After Additional Infant Deaths

An additional 70 infant deaths have been linked to recalled Fisher-Price Rock 'n Play Sleepers, which continue to be used by families despite the serious suffocation risks the design poses

Federal safety officials have re-announced a Fischer-Price recall that impacted nearly 5 million “Rock ‘n Play” infant sleepers, after receiving dozens of additional reports of infants becoming trapped and suffocating to death against the fabric years after the products were removed from the market.

The U.S. Consumer Product Safety Commission (CPSC) posted new information about the Fischer-Price infant sleeper recall on January 9, 2023, warning that many consumers are placing their children’s life at serious risk by continuing to use the recalled inclining sleepers.

Infant suffocation risks have been linked to a number of inclined sleeping products sold in recent years, including rockers, gliders, soothers, and swings. However, concerns over the design of Fisher-Price’s Rock ‘n Play sleepers were first raised in early 2019, after the products were linked to at least 30 infant fatalities.

According to the latest update, the CPSC has now become aware of an additional 70 infant deaths involving inclining sleeper products. The agency stated that Fisher-Price has been investigating the reported incidents and in some of the cases has been unable to confirm the circumstances or whether the product was a Rock ‘n Play Sleeper.

Fischer-Price Rock n’ Play Sleeper Recall

In early April 2019, the CPSC first raised concerns over the inclining design of Fischer-Price Rock ‘n Play infant sleepers, warning consumers to stop placing infants in the sleepers before they begin to show signs that they can roll over independently. Officials warned that infants may have the ability to roll over on their stomach and become trapped against the inclined bed, creating a suffocation risk.

Shortly after the initial CPSC warning, the American Academy of Pediatrics (AAP) issued a statement, calling for the commission to issue an immediate recall for the Rock’n Play Sleepers. The AAP determined the inclined sleepers were unsafe, and that the CPSC warning did not go far enough to ensure the safety of infants.

Just 12 days after the warning, the agency issued a Fisher-Price Rock ‘n Play Sleeper recall, impacting approximately 4.7 million units. The recalled included all models of Rock ‘n Play sleepers that were distributed for sale throughout the United States to major retailers for between $40 and $149 since 2009.

BABY FORMULA NEC LAWSUITS

Was your premature child fed Similac or Enfamil?

Premature infants fed Similac or Enfamil cow's milk formula face an increased risk of necrotizing enterocolitis (NEC) or wrongful death.

Learn More SEE IF YOU QUALIFY FOR COMPENSATION

Fischer- Price Rock ‘n Play Lawsuits

Following a nearly two year investigation after the recall, a House Oversight Committee report was released in June 2021, alleging Fisher-Price failed to adequately vet the Rock’n Play inclined infant sleeper for safety before putting it on the market in 2009, and indicating the manufacturer intentionally ignored pre-market warnings and concealed reports of infant deaths to avoid issuing costly recalls.

The report also revealed Fisher-Price and its parent company, Mattel Inc., were aware of dangers posed by the 30 degree inclining sleepers well before the products were available to consumers. According to the findings, the company’s internal safety committee raised alarms about the dangers posed by an inclined sleeper as early as 2008.

According to the report, Fisher-Price had documented at least 14 infant deaths in the sleepers by February 2018, which is more than a year prior to publicly recognizing any potential risks to consumers, and allegedly never reported the deaths to the CPSC.

Since the recalls, Fisher-Price has been hit with a number of inclined sleeper individual wrongful death lawsuits and at least 10 class action lawsuits alleging the manufacturer knew or should have known about the risk of problems, yet delayed announcing a recall or warning, and knowingly allowed parents to continue purchasing life-threatening sleeper devices.


Find Out If You Qualify for Infant Formula NEC Compensation

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Master Complaint Outlines Allegations in Ozempic, Wegovy, Mounjaro Lawsuits in MDL
Master Complaint Outlines Allegations in Ozempic, Wegovy, Mounjaro Lawsuits in MDL (Posted yesterday)

Plaintiffs pursuing GLP-1 injury lawsuits have filed a Master Complaint outlining common allegations being pursued against Novo Nordisk and Eli Lilly over their diabetes and weight loss drugs, including Ozempic, Wegovy, Mounjaro and others.

Six Years of Depo-Provera Injections Caused Woman To Develop Intracranial Meningioma: Lawsuit
Six Years of Depo-Provera Injections Caused Woman To Develop Intracranial Meningioma: Lawsuit (Posted 2 days ago)

California woman indicates she was unaware there was a link between her meningioma and Depo-Provera injections until a study was published in March 2024, resulting in widespread publicity about the brain tumor risks.